{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:30:10Z","timestamp":1794573010598,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pregnancy increases a woman\u2019s risk of severe dengue. To the best of our knowledge, the moderation effect of the dengue serotype among pregnant women has not been studied in Mexico. This study explores how pregnancy interacted with the dengue serotype from 2012 to 2020 in Mexico.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Information from 2469 notifying health units in Mexican municipalities was used for this cross-sectional analysis. Multiple logistic regression with interaction effects was chosen as the final model and sensitivity analysis was done to assess potential exposure misclassification of pregnancy status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Pregnant women were found to have higher odds of severe dengue [1.50 (95% CI 1.41, 1.59)]. The odds of dengue severity varied for pregnant women with DENV-1 [1.45, (95% CI 1.21, 1.74)], DENV-2 [1.33, (95% CI 1.18, 1.53)] and DENV-4 [3.78, (95% CI 1.14, 12.59)]. While the odds of severe dengue were generally higher for pregnant women compared with non-pregnant women with DENV-1 and DENV-2, the odds of disease severity were much higher for those infected with the DENV-4 serotype.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The effect of pregnancy on severe dengue is moderated by the dengue serotype. Future studies on genetic diversification may potentially elucidate this serotype-specific effect among pregnant women in Mexico.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08051-z","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:18:41Z","timestamp":1679861921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Moderation effects of serotype on dengue severity across pregnancy status in Mexico"],"prefix":"10.1186","volume":"23","author":[{"given":"Esther","family":"Annan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uyen-Sa D. T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Fairos","family":"Wan Yaacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Mangla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Kumar","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Nandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubydul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"issue":"3","key":"8051_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003547","volume":"9","author":"EA Undurraga","year":"2015","unstructured":"Undurraga EA, et al. Economic and disease burden of dengue in Mexico. PLoS Negl Trop Dis. 2015;9(3): e0003547.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"8051_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12879-021-06985-w","volume":"22","author":"BM Martin","year":"2022","unstructured":"Martin BM, et al. Clinical outcomes of dengue virus infection in pregnant and non-pregnant women of reproductive age: a retrospective cohort study from 2016 to 2019 in Paran\u00e1m Brazil. BMC Infect Dis. 2022;22(1):5\u20135.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"8051_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.21149\/8788","volume":"59","author":"J Pisanty-Alatorre","year":"2017","unstructured":"Pisanty-Alatorre J. Inequity in maternal mortality in Mexico: analyzing inequality on a sub-state regional scale. Salud Publica Mex. 2017;59(6):639\u201349.","journal-title":"Salud Publica Mex"},{"issue":"7","key":"8051_CR4","first-page":"357","volume":"78","author":"KY Ordaz-Mart\u00ednez","year":"2010","unstructured":"Ordaz-Mart\u00ednez KY, Rangel R, Hern\u00e1ndez-Gir\u00f3n C. Risk factors associated with maternal mortality in the State of Morelos, Mexico. Ginecol Obstet Mex. 2010;78(7):357\u201364.","journal-title":"Ginecol Obstet Mex"},{"key":"8051_CR5","doi-asserted-by":"publisher","first-page":"9643083","DOI":"10.1155\/2018\/9643083","volume":"2018","author":"C Machain-Williams","year":"2018","unstructured":"Machain-Williams C, et al. Maternal, fetal, and neonatal outcomes in pregnant dengue patients in Mexico. Biomed Res Int. 2018;2018:9643083.","journal-title":"Biomed Res Int"},{"issue":"11","key":"8051_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3855\/jidc.908","volume":"4","author":"S Kariyawasam","year":"2010","unstructured":"Kariyawasam S, Senanayake H. Dengue infections during pregnancy: case series from a tertiary care hospital in Sri Lanka. J Infect Dev Ctries. 2010;4(11):767\u201375.","journal-title":"J Infect Dev Ctries"},{"issue":"6","key":"8051_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/INF.0b013e318167917a","volume":"27","author":"W Phongsamart","year":"2008","unstructured":"Phongsamart W, et al. Dengue virus infection in late pregnancy and transmission to the infants. Pediatr Infect Dis J. 2008;27(6):500\u20134.","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"8051_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4269\/ajtmh.16-1018","volume":"97","author":"K Chang","year":"2017","unstructured":"Chang K, et al. Differences in mortality and clinical manifestations of dengue hemorrhagic fever in Taiwan in different years: a comparison for cases in 2014 and 2015 epidemics. Am J Trop Med Hyg. 2017;97(2):361\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"8051_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003812","volume":"9","author":"MG Teixeira","year":"2015","unstructured":"Teixeira MG, et al. Arterial hypertension and skin allergy are risk factors for progression from dengue to dengue hemorrhagic fever: a case control study. PLoS Negl Trop Dis. 2015;9(5): e0003812.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"8051_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000699","volume":"4","author":"MA Figueiredo","year":"2010","unstructured":"Figueiredo MA, et al. Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study. PLoS Negl Trop Dis. 2010;4(6): e699.","journal-title":"PLoS Negl Trop Dis"},{"issue":"20","key":"8051_CR11","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1056\/NEJMoa1605368","volume":"375","author":"J Alegre-D\u00edaz","year":"2016","unstructured":"Alegre-D\u00edaz J, et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med. 2016;375(20):1961\u201371.","journal-title":"N Engl J Med"},{"issue":"suppl_1","key":"8051_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/nutrit\/nuw030","volume":"75","author":"OY Bello-Chavolla","year":"2017","unstructured":"Bello-Chavolla OY, et al. Epidemiology of diabetes mellitus in Mexico. Nutr Rev. 2017;75(suppl_1):4\u201312.","journal-title":"Nutr Rev"},{"issue":"8","key":"8051_CR13","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760180082","volume":"113","author":"GL Werneck","year":"2018","unstructured":"Werneck GL, et al. Comorbidities increase in-hospital mortality in dengue patients in Brazil. Mem Inst Oswaldo Cruz. 2018;113(8): e180082.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"8051_CR14","first-page":"102","volume":"105","author":"AE Macias","year":"2021","unstructured":"Macias AE, et al. Mortality among hospitalized dengue patients with comorbidities in Mexico, Brazil, and Colombia. Am J Trop Med Hyg. 2021;105(1):102.","journal-title":"Am J Trop Med Hyg"},{"key":"#cr-split#-8051_CR15.1","unstructured":"Organization, W.H. Women of reproductive age (15-49 years) population (thousands). 2022"},{"key":"#cr-split#-8051_CR15.2","unstructured":"https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/women-of-reproductive-age-(15-49-years)-population-(thousands). Accessed 25 Jan 2022."},{"key":"8051_CR16","unstructured":"Secretar\u00eda de Salud, M. Lineamientos Para La Vigilancia Por Laboratorio Del Dengue Y Otras Arbovirosis, Indre (Instituto De Diagn\u00f3stico Y Referencia Epidemiol\u00f3gicos \u2018Dr. Manuel Mart\u00ednez B\u00c1EZ\u2019). 2021; https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/629265\/Lineamientos_Dengue_Arb_V1-2021.pdf."},{"issue":"6","key":"8051_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/cid\/cir451","volume":"53","author":"A Srikiatkhachorn","year":"2011","unstructured":"Srikiatkhachorn A, et al. Dengue\u2013how best to classify it. Clin Infect Dis. 2011;53(6):563\u20137.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"8051_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/pathogens9110964","volume":"9","author":"S Ananth","year":"2020","unstructured":"Ananth S, et al. Clinical symptoms of arboviruses in Mexico. Pathogens. 2020;9(11):964.","journal-title":"Pathogens"},{"key":"8051_CR19","unstructured":"Analytics, U.A.R.C.S.M.a.D. Introduction to Generalized Linear Mixed Models. 2021; https:\/\/stats.oarc.ucla.edu\/other\/mult-pkg\/introduction-to-generalized-linear-mixed-models\/. 4 Mar 2022."},{"issue":"4","key":"8051_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.EDE.0000071419.41011.cf","volume":"14","author":"TL Lash","year":"2003","unstructured":"Lash TL, Fink AK. Semi-automated sensitivity analysis to assess systematic errors in observational data. Epidemiology. 2003;14(4):451.","journal-title":"Epidemiology"},{"key":"8051_CR21","unstructured":"Analysis, B. Applying quantitative bias analysis to epidemiologic data. n.d.; https:\/\/sites.google.com\/site\/biasanalysis\/Home. 28 Jan 2022."},{"issue":"6","key":"8051_CR22","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/ije\/dyu149","volume":"43","author":"TL Lash","year":"2014","unstructured":"Lash TL, et al. Good practices for quantitative bias analysis. Int J Epidemiol. 2014;43(6):1969\u201385.","journal-title":"Int J Epidemiol"},{"key":"8051_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104391","volume":"84","author":"E Hern\u00e1ndez-Garc\u00eda","year":"2020","unstructured":"Hern\u00e1ndez-Garc\u00eda E, et al. Epidemiological implications of the genetic diversification of dengue virus (DENV) serotypes and genotypes in Mexico. Infect Genet Evol. 2020;84: 104391.","journal-title":"Infect Genet Evol"},{"issue":"2","key":"8051_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3201\/eid2302.160751","volume":"23","author":"S Shihada","year":"2017","unstructured":"Shihada S, et al. Genetic diversity and new lineages of dengue virus serotypes 3 and 4 in returning travelers, Germany, 2006\u20132015. Emerg Infect Dis. 2017;23(2):272\u20135.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"8051_CR25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4269\/ajtmh.14-0628","volume":"92","author":"C-F Yung","year":"2015","unstructured":"Yung C-F, et al. Dengue serotype-specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, singapore. Am J Trop Med Hyg. 2015;92(5):999\u20131005.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"8051_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000617","volume":"4","author":"JR Fried","year":"2010","unstructured":"Fried JR, et al. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis. 2010;4(3): e617.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"8051_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4269\/ajtmh.2006.74.449","volume":"74","author":"A Balmaseda","year":"2006","unstructured":"Balmaseda A, et al. Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg. 2006;74(3):449\u201356.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"8051_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4269\/ajtmh.2003.68.191","volume":"68","author":"A Nisalak","year":"2003","unstructured":"Nisalak A, et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg. 2003;68(2):191\u2013202.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"8051_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1086\/315215","volume":"181","author":"DW Vaughn","year":"2000","unstructured":"Vaughn DW, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181(1):2\u20139.","journal-title":"J Infect Dis"},{"issue":"9","key":"8051_CR30","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/v12090913","volume":"12","author":"A Aryati","year":"2020","unstructured":"Aryati A, et al. dengue virus serotype 4 is responsible for the outbreak of dengue in East Java City of Jember, Indonesia. Viruses. 2020;12(9):913.","journal-title":"Viruses"},{"issue":"3","key":"8051_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.pop.2018.05.013","volume":"45","author":"C Leeper","year":"2018","unstructured":"Leeper C, Lutzkanin A 3rd. Infections during pregnancy. Prim Care. 2018;45(3):567\u201386.","journal-title":"Prim Care"},{"key":"8051_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0065-3527(03)59009-1","volume":"59","author":"R Rico-Hesse","year":"2003","unstructured":"Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv Virus Res. 2003;59:315\u201341.","journal-title":"Adv Virus Res"},{"key":"8051_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2019.103977","volume":"75","author":"K Suzuki","year":"2019","unstructured":"Suzuki K, et al. Genotype replacement of dengue virus type 3 and clade replacement of dengue virus type 2 genotype Cosmopolitan in Dhaka, Bangladesh in 2017. Infect Genet Evol. 2019;75: 103977.","journal-title":"Infect Genet Evol"},{"issue":"24","key":"8051_CR34","doi-asserted-by":"publisher","first-page":"15123","DOI":"10.1128\/JVI.79.24.15123-15130.2005","volume":"79","author":"C Zhang","year":"2005","unstructured":"Zhang C, et al. Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J Virol. 2005;79(24):15123\u201330.","journal-title":"J Virol"},{"issue":"6","key":"8051_CR35","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1590\/S0034-89102010005000040","volume":"44","author":"MI Gonz\u00e1lez Fern\u00e1ndez","year":"2010","unstructured":"Gonz\u00e1lez Fern\u00e1ndez MI, Orozco N\u00fa\u00f1ez E, Cifuentes E. Policy analysis of the dengue control program in Mexico. Rev Saude Publica. 2010;44(6):1079\u201386.","journal-title":"Rev Saude Publica"},{"issue":"3","key":"8051_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212987","volume":"14","author":"E Davalos-Becerril","year":"2019","unstructured":"Davalos-Becerril E, et al. Urban and semi-urban mosquitoes of Mexico City: a risk for endemic mosquito-borne disease transmission. PLoS ONE. 2019;14(3): e0212987.","journal-title":"PLoS ONE"},{"key":"8051_CR37","unstructured":"Travellers, I.A.f.M.A.t. Mexico General Health Risks: Dengue. 2020; https:\/\/www.iamat.org\/country\/mexico\/risk\/dengue#. 22 Feb 2022."},{"issue":"3","key":"8051_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jcv.2009.05.007","volume":"45","author":"J G\u00fcnther","year":"2009","unstructured":"G\u00fcnther J, et al. Distribution of dengue cases in the state of Oaxaca, Mexico, during the period 2004\u20132006. J Clin Virol. 2009;45(3):218\u201322.","journal-title":"J Clin Virol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08051-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08051-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08051-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:19:00Z","timestamp":1679861940000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08051-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8051"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08051-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"12 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the \u201cNorth Texas Regional Institutional Review Board\u201d as an exempt category (reference # 2021-035) and all methods were performed in accordance with the Declaration of Helsinki guidelines for reporting observational studies. The need for informed consent was waived by the North Texas Regional IRB because the data analyzed was aggregated, de-identified and delinked, and therefore, obtaining informed consent was not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable since we received and analyzed the deidentified and delinked aggregated retrospective data at the municipality level. This data was aggregated and compiled by the Ministry of Health, Mexico through nationally disease surveillance reporting system.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}